GlassScriptPhysician profile
Dannie Lynn Perdomo
NPI 1861997561
$1,648.64
in general payments reported to CMS, 2019-2025
16 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 93% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $459 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,648.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $419.96 | 2024-2025 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.82 | 2025 | Xifaxan |
| Novo Nordisk INC | $169.22 | 2024-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $134.24 | 2025 | |
| Phadia US INC. | $94.03 | 2025 | Immunocap |
| Hologic Sales and Service, LLC | $92.49 | 2024-2025 | Aptima |
| Genzyme Corporation | $91.98 | 2024 | |
| Gilead Sciences, INC. | $82.63 | 2024-2025 | |
| Viiv Healthcare Company | $67.72 | 2024-2025 | Apretude |
| Exact Sciences Corporation | $64.26 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $57.30 | 2025 | |
| Abbvie INC. | $34.71 | 2025 | |
| Lilly USA, LLC | $28.47 | 2024 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.26 | 2025 | |
| Glaxosmithkline, LLC. | $22.07 | 2025 | Shingrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tms Neurohealth Centers INC. | $12.48 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dannie Perdomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.